Albert Einstein College of Medicine

Projects

Projects per year 1975 1985 1989 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 37 Not started
• 344 Active
• 4466 Finished

Projects per year

Search results

• Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance

  Macian, F., Guha, C. & Macian-Juan, F.

  National Cancer Institute

  4/1/18 → 12/31/18

  Project: Research project

  • Neoplasm Antigens 100%
  • Melanoma 81%
  • Tumor Microenvironment 65%
  • T-Lymphocytes 60%
  • Immunosuppressive Agents 52%

• Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance

  Guha, C. & Macian-Juan, F.

  4/1/18 → 3/31/22

  Project: Research project

  • Melanoma 100%
  • Neoplasm Antigens 96%
  • T-Lymphocytes 74%
  • Tumor Microenvironment 62%
  • Immunosuppressive Agents 50%

• USE OF MODIFIED EKLF FOR GAMMA GLOBIN AUGMENTATION

  Manwani, D. G.

  9/30/00 → 8/31/05

  Project: Research project

  • erythroid Kruppel-like factor 100%
  • gamma-Globins 64%
  • Fetal Hemoglobin 38%
  • Globins 36%
  • beta-Globins 35%

• USE OF MODIFIED EKLF FOR GAMMA GLOBIN AUGMENTATION

  Manwani, D. G.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/00 → 8/31/04

  Project: Research project

  • erythroid Kruppel-like factor 100%
  • gamma-Globins 82%
  • Fetal Hemoglobin 49%
  • Globins 46%
  • beta-Globins 45%

• Using a Social-Ecological Framework to Support Community Health Research

  Walker, E. A. & Hernandez, P.

  National Institute on Minority Health and Health Disparities

  7/6/10 → 9/30/13

  Project: Research project

  • Urban Health 100%
  • Public Health 61%
  • Health 47%
  • Data Management 21%
  • Organizations 13%

• Using a Social-Ecological Framework to Support Community Health Research

  Hernandez, P. & Walker, E. A.

  7/6/10 → 9/30/13

  Project: Research project

  • Urban Health 100%
  • Health 47%
  • Public Health 34%
  • Data Management 21%
  • Organizations 13%

• Using cortico-striatal evolutionary innovations for modeling Huntington's disease

  Mehler, M. F.

  8/1/18 → 4/30/21

  Project: Research project

  • animal models 100%
  • mice 76%
  • mutants 44%
  • therapeutics 44%
  • human diseases 40%

• Using cortico-striatal evolutionary innovations for modeling Huntington's disease

  Mehler, M. F. & Mehler, M. F.

  NIH Office of the Director

  8/1/18 → 4/30/21

  Project: Research project

  • animal models 100%
  • mice 76%
  • mutants 44%
  • therapeutics 44%
  • human diseases 40%

• Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia

  George, C. J.

  9/15/20 → 5/31/22

  Project: Research project

  • Cognitive Dysfunction 100%
  • Angiotensin-Converting Enzyme Inhibitors 85%
  • Gait 66%
  • Retirement 41%
  • Organized Financing 41%

• Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines ? The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle

  GAMARNIK, V. & Gong, M. N.

  National Heart, Lung, and Blood Institute

  9/2/16 → 4/30/19

  Project: Research project

  • Ventilator-Associated Pneumonia 100%
  • Patient Compliance 63%
  • Guidelines 48%
  • Technology 40%
  • Critical Care 22%

• Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines ? The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle

  Gong, M. N.

  9/2/16 → 4/30/19

  Project: Research project

  • Ventilator-Associated Pneumonia 100%
  • Guidelines 43%
  • Critical Care 39%
  • Patient Compliance 32%
  • National Heart, Lung, and Blood Institute (U.S.) 15%

• Vaccines for Extensively Drug Resistant Tuberculosis

  Jacobs Jr., W. R., Rose, S. A. & Rose, S. A.

  5/1/12 → 4/30/18

  Project: Research project

  • Tuberculosis 100%
  • Vaccines 60%
  • Smegma 43%
  • Extensively Drug-Resistant Tuberculosis 40%
  • Mycobacterium bovis 29%

• Vaccines for Extensively Drug Resistant Tuberculosis

  Jacobs, W. R. & Jacobs Jr., W. R.

  National Institute of Allergy and Infectious Diseases

  5/1/12 → 4/30/15

  Project: Research project

  • Extensively Drug-Resistant Tuberculosis 100%
  • Tuberculosis 61%
  • Vaccines 53%
  • Mycobacterium bovis 25%
  • Smegma 20%

• VALIDATION OF MRI PERFUSION TECHNIQUES

  Branch, C. A.

  National Institute of Neurological Disorders and Stroke

  5/1/98 → 3/31/03

  Project: Research project

  • magnetic resonance imaging 100%
  • methodology 22%
  • blood flow 17%
  • labeling techniques 11%
  • partition coefficients 11%

• VALIDATION OF MRI PERFUSION TECHNIQUES

  Branch, C. A.

  5/1/98 → 3/31/03

  Project: Research project

  • magnetic resonance imaging 100%
  • methodology 40%
  • blood flow 28%
  • labeling techniques 19%
  • partition coefficients 18%

• VANADIUM SALTS AND CARBOHYDRATE METABOLISM

  Shamoon, H. & Rossetti, L.

  9/30/93 → 9/29/98

  Project: Research project

  • Glucose 100%
  • Insulin 92%
  • Vanadates 88%
  • Glycolysis 71%
  • Glycogen 70%

• VANADIUM SALTS AND CARBOHYDRATE METABOLISM

  Shamoon, H. H., Rossetti, L. L., Shamoon, H. & Rossetti, L.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/93 → 9/29/98

  Project: Research project

  • Glucose 100%
  • Pharmacological Metabolism 61%
  • Carbohydrate 60%
  • Glycogen 54%
  • Insulin Derivative 34%

• Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

  Nahvi, S.

  9/21/10 → 8/31/16

  Project: Research project

  • Methadone 100%
  • Smoking Cessation 87%
  • Directly Observed Therapy 53%
  • Varenicline 51%
  • Smokers 36%

• Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

  Nahvi, S. & Nahvi, S.

  National Institute on Drug Abuse

  9/21/10 → 8/31/16

  Project: Research project

  • Varenicline 100%
  • Methadone 84%
  • Withholding Treatment 77%
  • Smoking Cessation 72%
  • Directly Observed Therapy 54%

• Variable Gene Defects and Pneumococcal Susceptibility

  Pirofski, L. & Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  4/1/01 → 3/31/04

  Project: Research project

  • Polysaccharides 100%
  • Pneumococcal Vaccines 99%
  • Pneumococcal Infections 78%
  • Antibodies 63%
  • Genes 57%

• VARIABLE GENE DEFECTS AND PNEUMOCOCCAL SUSCEPTIBILITY

  Pirofski, L. & Rose, S. A.

  4/1/01 → 4/30/12

  Project: Research project

  • Polysaccharides 100%
  • Pneumococcal Infections 58%
  • Pneumococcal Vaccines 44%
  • Molecular Structure 42%
  • Antibodies 32%

• Variable Gene Use and Pneumococcal Immunity in AIDS

  Pirofski, L. & Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  7/1/00 → 1/31/12

  Project: Research project

  • Acquired Immunodeficiency Syndrome 100%
  • Immunity 97%
  • Vaccines 73%
  • Streptococcus pneumoniae 71%
  • Genes 48%

• VARIABLE GENE USE AND PNEUMOCOCCAL IMMUNITY IN AIDS

  Pirofski, L. & Rose, S. A.

  7/1/00 → 1/31/12

  Project: Research project

  • Streptococcus pneumoniae 100%
  • Antibodies 66%
  • HIV 60%
  • HIV Infections 48%
  • Epitopes 46%

• VARIANTS OF HIV WITH INCREASED POLYMERASE FIDELITY

  Prasad, V. R.

  1/15/97 → 1/14/01

  Project: Research project

  • Lamivudine 100%
  • Mutation Rate 52%
  • Research Personnel 46%
  • Ritonavir 42%
  • HIV 34%

• VARIANTS OF HIV WITH INCREASED POLYMERASE FIDELITY

  Prasad, V. R.

  National Institute of Allergy and Infectious Diseases

  1/15/97 → 1/14/01

  Project: Research project

  • Lamivudine 100%
  • Mutation Rate 52%
  • HIV 51%
  • Research Personnel 46%
  • Ritonavir 42%

• Vascular Structure and Function in Cognitive Aging

  Lipton, R. B.

  National Institute on Aging

  4/1/11 → 3/31/16

  Project: Research project

  • Cognitive Aging 100%
  • Dementia 73%
  • Blood Vessels 45%
  • Cognitive Dysfunction 43%
  • Doppler Ultrasonography 27%

• Vcsa1 (hSMR3A) as a Marker for Diabetes

  Davies, K. & Rose, S. A.

  7/19/07 → 6/30/10

  Project: Research project

  • sialorphin 100%
  • Blood Vessels 68%
  • Diabetes Complications 46%
  • Immunoassay 46%
  • Saliva 45%

• Vcsa1 (hSMR3A) as a Marker for Diabetes

  Davies, K.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/19/07 → 6/30/10

  Project: Research project

  • sialorphin 100%
  • Blood Vessels 68%
  • Diabetes Complications 46%
  • Immunoassay 46%
  • Saliva 45%

• VEGF-based targeted imaging of tumor vasculature

  Backer, J. M.

  2/8/05 → 8/31/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • CY5.5 cyanine dye 41%
  • Contrast Media 22%
  • Neoplasms 21%
  • Recombinant Fusion Proteins 11%

• VEGF-driven PET imaging of tumor angiogenesis

  Backer, J. M.

  8/10/07 → 2/29/08

  Project: Research project

  • Vascular Endothelial Growth Factor Receptor 100%
  • Neoplasms 53%
  • Molecular Imaging 49%
  • Vascular Endothelial Growth Factor A 35%
  • Phase II Clinical Trials 16%

• VEGF Induced Signal Transduction

  Sibinga, N. E. S., Terman, B. I. & Sibinga, N. E. S.

  National Cancer Institute

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 74%
  • Cell Proliferation 37%
  • Reactive Oxygen Species 22%
  • Non-Receptor Type 6 Protein Tyrosine Phosphatase 22%

• VEGF INDUCED SIGNAL TRANSDUCTION

  Sibinga, N. E. S., Terman, B., Rose, S. A. & Rose, S. A.

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 90%
  • Neoplasms 87%
  • Nutrients 65%
  • Endothelial Cells 57%

• VIBRATIONAL AND DYNAMICAL STUDIES OF ENZYMES

  Callender, R. R., Callender, R. & Callender, R.

  National Institute of General Medical Sciences

  8/30/85 → 7/31/03

  Project: Research project

  • Enzymes 100%
  • Yersinia 67%
  • Tetrahydrofolate Dehydrogenase 65%
  • NAD 56%
  • dihydroneopterin aldolase 52%

• Viral Immunoregulatory Genes and Hepatocyte Transplants

  Roy-Chowdhury, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  2/1/05 → 1/31/10

  Project: Research project

  • Viral Genes 100%
  • Hepatocytes 87%
  • Adenoviridae 70%
  • Transplants 53%
  • Liver 21%

• Viral Immunoregulatory Genes in Beta Cells to Treat Diabetes

  Goldstein, H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/07 → 7/31/09

  Project: Research project

• VIROLOGY AND OPPORTUNISTIC INFECTIONS

  Horwitz, M. & Baum, S. G.

  National Institute of Allergy and Infectious Diseases

  10/1/84 → 9/30/89

  Project: Research project

• Visual Cortical Adaptation

  Kohn, A. & Kohn, A.

  National Eye Institute

  9/1/08 → 1/31/19

  Project: Research project

  • Neurons 100%
  • Visual Cortex 59%
  • Population 58%
  • Brain 36%
  • History 32%

• Visual Crowding

  Kohn, A.

  2/1/18 → 1/31/22

  Project: Research project

  • Crowding 100%
  • Visual Cortex 9%
  • Ocular Vision 7%
  • Population 7%
  • Animals 6%

• Visual Crowding

  Kohn, A. & Kohn, A.

  National Eye Institute

  2/1/18 → 1/31/23

  Project: Research project

  • Crowding 100%
  • Visual Cortex 9%
  • Ocular Vision 8%
  • Animals 7%
  • Population 6%

• Visual-somatosensory integration as a novel marker of Alzheimer's disease

  Mahoney, J. R.

  2/15/22 → 1/31/23

  Project: Research project

  • Alzheimer Disease 100%
  • Neurobiology 25%
  • Prefrontal Cortex 19%
  • Accidental Falls 17%

• Visual-somatosensory integration as a novel marker of Alzheimer's disease

  Mahoney, J. R.

  National Institute on Aging

  2/15/22 → 1/31/23

  Project: Research project

  • Alzheimer Disease 100%
  • Neurobiology 27%
  • Prefrontal Cortex 21%
  • Accidental Falls 18%

• Vitamin D3 and Intestinal Tumorigenesis

  Augenlicht, L. H. & Rose, S. A.

  12/1/09 → 11/30/12

  Project: Research project

  • Cholecalciferol 100%
  • Macrophages 44%
  • Epithelial Cells 41%
  • Neoplasms 20%
  • Colonic Neoplasms 15%

• Vitamin D3 and Intestinal Tumorigenesis

  Augenlicht, L. H.

  National Cancer Institute

  12/1/09 → 11/30/12

  Project: Research project

  • Cholecalciferol 100%
  • Macrophages 46%
  • Carcinogenesis 45%
  • Epithelial Cells 43%
  • Neoplasms 21%

• VOLTAGE DEPENDENCE OF JUNCTIONAL CONDUCTANCE

  Bennett, M. V. L.

  National Institute of Neurological Disorders and Stroke

  10/1/84 → 9/30/89

  Project: Research project

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Zhao, H. & Schwartz, E. L.

  4/12/19 → 3/31/22

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 17%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 11%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Schwartz, E. L. & Zhao, H.

  National Cancer Institute

  4/12/19 → 3/31/21

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 18%
  • Heterografts 17%
  • Ubiquitination 13%
  • Neoplasms 12%

• WEIGHT MGT &NUTRITION FOR PRE-/PERIMENOPAUSAL BREAST CANCER SURVIVORS

  Wylie-Rosett, J.

  National Center for Research Resources

  10/1/98 → 9/30/01

  Project: Research project

  • breast neoplasms 100%
  • weight gain 59%
  • menopause 56%
  • nutrition 56%
  • estradiol 54%

• Wellness Program Implementation: School & Student Toolkits

  Wylie-Rosett, J. & Wylie-Rosett, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/13 → 7/31/15

  Project: Research project

  • health promotion 100%
  • Dietary Guidelines 96%
  • planning 95%
  • students 95%
  • obesity 70%

• Wellness Program Implementation: School & Student Toolkits

  Wylie-Rosett, J. & Rose, S. A.

  9/1/13 → 10/31/18

  Project: Research project

  • Dietary Guidelines 100%
  • planning 99%
  • obesity 73%
  • students 70%
  • sedentary lifestyle 54%

• Westchester Square Partnership

  Karasz, A. & Rose, S. A.

  8/25/08 → 5/31/11

  Project: Research project

  • mental disorder 100%
  • psychiatric treatment 64%
  • project planning 62%
  • clinical services 61%
  • community service 51%